These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

483 related articles for article (PubMed ID: 32226547)

  • 21. Yin Yang 1 facilitates hepatocellular carcinoma cell lipid metabolism and tumor progression by inhibiting PGC-1β-induced fatty acid oxidation.
    Li Y; Kasim V; Yan X; Li L; Meliala ITS; Huang C; Li Z; Lei K; Song G; Zheng X; Wu S
    Theranostics; 2019; 9(25):7599-7615. PubMed ID: 31695789
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transcriptional factor Yin Yang 1 facilitates the stemness of ovarian cancer via suppressing miR-99a activity through enhancing its deacetylation level.
    Qian S; Wang W; Li M
    Biomed Pharmacother; 2020 Jun; 126():110085. PubMed ID: 32199224
    [TBL] [Abstract][Full Text] [Related]  

  • 23. YY1 regulates melanoma tumorigenesis through a miR-9 ~ RYBP axis.
    Zhao G; Li Q; Wang A; Jiao J
    J Exp Clin Cancer Res; 2015 Jun; 34(1):66. PubMed ID: 26104682
    [TBL] [Abstract][Full Text] [Related]  

  • 24. YY1 regulates cancer cell immune resistance by modulating PD-L1 expression.
    Hays E; Bonavida B
    Drug Resist Updat; 2019 Mar; 43():10-28. PubMed ID: 31005030
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional analysis of YY1 zinc fingers through cysteine mutagenesis.
    Chen K; Lu Y; Shi K; Stovall DB; Li D; Sui G
    FEBS Lett; 2019 Jun; 593(12):1392-1402. PubMed ID: 31127623
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cistrome analysis of YY1 uncovers a regulatory axis of YY1:BRD2/4-PFKP during tumorigenesis of advanced prostate cancer.
    Xu C; Tsai YH; Galbo PM; Gong W; Storey AJ; Xu Y; Byrum SD; Xu L; Whang YE; Parker JS; Mackintosh SG; Edmondson RD; Tackett AJ; Huang J; Zheng D; Earp HS; Wang GG; Cai L
    Nucleic Acids Res; 2021 May; 49(9):4971-4988. PubMed ID: 33849067
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oncogenic potential of yin yang 1 mediated through control of imprinted genes.
    Thiaville MM; Kim J
    Crit Rev Oncog; 2011; 16(3-4):199-209. PubMed ID: 22248054
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multifunctional transcription factor YY1: a therapeutic target in human cancer?
    Wang CC; Chen JJ; Yang PC
    Expert Opin Ther Targets; 2006 Apr; 10(2):253-66. PubMed ID: 16548774
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Multilayered Regulation of the Oncogenic Protein YY1.
    Rizkallah R; Hurt MM
    Crit Rev Oncog; 2017; 22(1-2):109-129. PubMed ID: 29604940
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Forgotten YY2 in Reported YY1 Expression Levels in Human Cancers.
    Kaufhold S; Aziz N; Bonavida B
    Crit Rev Oncog; 2017; 22(1-2):63-73. PubMed ID: 29604937
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Zinc-finger protein YY1 suppresses tumor growth of human nasopharyngeal carcinoma by inactivating c-Myc-mediated
    Li M; Liu Y; Wei Y; Wu C; Meng H; Niu W; Zhou Y; Wang H; Wen Q; Fan S; Li Z; Li X; Zhou J; Cao K; Xiong W; Zeng Z; Li X; Qiu Y; Li G; Zhou M
    J Biol Chem; 2019 Apr; 294(15):6172-6187. PubMed ID: 30718276
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic targeting of YY1/MZF1 axis by MZF1-uPEP inhibits aerobic glycolysis and neuroblastoma progression.
    Fang E; Wang X; Wang J; Hu A; Song H; Yang F; Li D; Xiao W; Chen Y; Guo Y; Liu Y; Li H; Huang K; Zheng L; Tong Q
    Theranostics; 2020; 10(4):1555-1571. PubMed ID: 32042322
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Yin Yang 1 overexpression in diffuse large B-cell lymphoma is associated with B-cell transformation and tumor progression.
    Castellano G; Torrisi E; Ligresti G; Nicoletti F; Malaponte G; Traval S; McCubrey JA; Canevari S; Libra M
    Cell Cycle; 2010 Feb; 9(3):557-63. PubMed ID: 20081364
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Yin Yang 2: the great unknown within the Yin Yang 1 regulatory network.
    Klar M
    Crit Rev Oncog; 2011; 16(3-4):239-43. PubMed ID: 22248057
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of transcription factor Yin Yang 1 in prostate cancer.
    Seligson D; Horvath S; Huerta-Yepez S; Hanna S; Garban H; Roberts A; Shi T; Liu X; Chia D; Goodglick L; Bonavida B
    Int J Oncol; 2005 Jul; 27(1):131-41. PubMed ID: 15942652
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting the Overexpressed YY1 in Cancer Inhibits EMT and Metastasis.
    Cho AA; Bonavida B
    Crit Rev Oncog; 2017; 22(1-2):49-61. PubMed ID: 29604936
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Yin yang 1 expression in human tumors.
    Zaravinos A; Spandidos DA
    Cell Cycle; 2010 Feb; 9(3):512-22. PubMed ID: 20081375
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transcription factor YY1: structure, function, and therapeutic implications in cancer biology.
    Gordon S; Akopyan G; Garban H; Bonavida B
    Oncogene; 2006 Feb; 25(8):1125-42. PubMed ID: 16314846
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transcription Factor YY1 Modulates Lung Cancer Progression by Activating lncRNA-PVT1.
    Huang T; Wang G; Yang L; Peng B; Wen Y; Ding G; Wang Z
    DNA Cell Biol; 2017 Nov; 36(11):947-958. PubMed ID: 28972861
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Yin Yang 1-mediated epigenetic silencing of tumour-suppressive microRNAs activates nuclear factor-κB in hepatocellular carcinoma.
    Tsang DP; Wu WK; Kang W; Lee YY; Wu F; Yu Z; Xiong L; Chan AW; Tong JH; Yang W; Li MS; Lau SS; Li X; Lee SD; Yang Y; Lai PB; Yu DY; Xu G; Lo KW; Chan MT; Wang H; Lee TL; Yu J; Wong N; Yip KY; To KF; Cheng AS
    J Pathol; 2016 Apr; 238(5):651-64. PubMed ID: 26800240
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.